Status:
WITHDRAWN
The Potential Therapeutic Effect of Melatonin in Gastro-Esophageal Reflux Disease
Lead Sponsor:
Mansoura University
Conditions:
Gastroesophageal Reflux Disease
Eligibility:
All Genders
42-56 years
Phase:
PHASE3
Brief Summary
Gastro-Esophageal Reflux Disease was defined as a condition that develops when the reflux of stomach contents causes troublesome symptoms and/or complications. Many drugs used for the treatment of GER...
Eligibility Criteria
Inclusion
- patient with GERD ranged from 42 to 56 years
Exclusion
- patients with cardiac disease
- patients with renal affection
- patients with liver diseases (due to drug induced, autoimmune disease and viral hepatitis)
- patients on the drugs known to affect the GIT motility (phenothiazines, anticholinergics, nitrates or calcium channel blockers) were excluded during the time of conduction of the study or the preceding two weeks
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00915616
Last Update
June 8 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.